Trials
Search / Trial NCT06422429

Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health

Launched by YU ZHANG · May 17, 2024

Trial Information

Current as of February 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Participants entered the trial with a 1-week equilibration period during which baked and fried foods were prohibited. The test group will consume personalised innovative Youtiao and the control group will uniformly consume traditional Youtiao of equal energy, 45 g 4 times per week for 8 weeks, during which time we will periodically measure biological indicators and collect biological samples to gain insight into the effects of the personalised innovative Youtiao on the participants. After completion of the 8-week intervention, a washout phase is entered. During this phase, participants will...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 40-70 years old (women need to be menopausal);
  • BMI\>24 kg/m2;
  • Consumption of fritters more than once a week.
  • Exclusion Criteria:
  • history of diabetes mellitus, cardiovascular disease, dyslipidaemia, renal disease, -
  • liver disease or cancer;
  • surgical treatment within 3 months;
  • allergy/intolerance to the study food or any of its ingredients;
  • breastfeeding or pregnancy;
  • \>10% weight loss in the past 6 months;
  • smoking or alcohol abuse;
  • participation in another clinical study within the past 6 months

About Yu Zhang

Yu Zhang is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative studies. With a commitment to scientific rigor and ethical standards, Yu Zhang collaborates with leading researchers and healthcare professionals to design and implement clinical trials that explore new therapies and treatment modalities. By fostering a culture of transparency and collaboration, Yu Zhang aims to contribute to the development of groundbreaking solutions that address unmet medical needs and enhance the quality of care for patients worldwide.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0